Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

Share:
More In Business
Dow Shows First Weekly Gain Since Late January
Danielle DiMartino Booth, CEO and chief strategist of Quill Intelligence, joined Cheddar News to discuss the market that is still digesting comments from the Federal Reserve about its monetary policy.
Load More